The global local anesthesia drugs market size is estimated to expand at a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing number of surgeries which requires local anesthesia, high usage of local anesthetic to treat postoperative pain, and rising number of product approvals.
Anesthesia is a medical drug that prevents or reduces the pain during painful events of treatment such as surgery. It causes loss of normal sensation or awareness to the patient who are undergoing a surgical operation, which makes easy for the surgeon to carry out surgery effectively. An anesthesia is a drug that inhibits pain sensation of the patients during a medical operation and can be applied to ensure numb of a particular part of the body. The use of anesthesia for particular applications is widely associated with surgeries of hand, legs, minor stitching of a wound, or any minor pain in any part of the body. The local anesthesia has proved to be of great importance as it reduces risk of overdoses of the drug. The count of surgeries is increasing rapidly with every passing year due to rising incidence of road accidents and sport injuries. The local anesthesia (LA) is widely used in the post-operative treatment as a part of pain management. As a global health report, an estimated 65% of the total surgeries performed are required for post-operative pain management solution. This increases the market range and gives substantial numbers to the market growth.
The COVID-19 pandemic has boosted the market growth as the use of LA for the treatment of COVID-19 patients is increasing because of its effectiveness and minimal risk of viral transmission. Furthermore, as per the research article published in the European Archives of Oto-Rhino-Laryngology in 2020, the use of topical oropharyngeal lignocaine is considerably elevated due to the comfort for the people during oropharyngeal sampling for COVID-19. This procedure had no effect on the detection of SARS-CoV-2 in the upper respiratory track but it has wide application in the COVID-19 sampling.
Market Trends, Drivers, Restraints, and Opportunities
- Rise in the number of surgeries performed due to increasing aging population and rising cases of chronic diseases such as cancer, cardiovascular disorders, and neurological disorders are expected to push the market expansion.
- Advancement in drug delivery technologies to expand medical science is anticipated to bolster the demand for local anesthetics. This is anticipated to boost the market.
- Approvals and rapid development of novel LA drugs along with high funding for research and development prove to be key factors for growth of the market.
- Concerning issues regarding side-effect of the drugs and strict regulatory guidelines are some of the restraints that can hinder the market growth.
Scope of the Report
The report on the global local anesthesia drugs market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
| Attributes | Details |
| Report Title | Local Anesthesia Drugs Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
| Base Year | 2020 |
| Historic Data | 2018–2019 |
| Forecast Period | 2021–2028 |
| Segmentation | Products (Umbilical Cord, Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine, and Others) and Drug Applications (Injectable Anesthetic and Surface Anaesthetic) |
| Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
| Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
| Key Players Covered in the Report | Astrazeneca PLC; Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Hikma Pharmaceuticals PLC; Baxter International Inc.; Hospira, Inc.; AbbVie Inc.; and Fresenius Se & Co. Kgaa. |
Market Segment Insights
Bupivacaine segment is expected to grow at a rapid pace
Based on products, the global local anesthesia drugs market is divided into umbilical cord, ropivacaine, bupivacaine, lidocaine, prilocaine, chloroprocaine, benzocaine, and others. The bupivacaine segment is expected to grow at a rapid pace during the projected period as the drug is extremely useful for various procedures such as therapeutic, surgery and diagnostic, and obstetrical procedures. Bupivacaine is extensively used as LA because of its efficacy in anesthetization of specific organs.
On the other hand, the Lidocaine segment is projected to account for a key market share in the coming years owing to high demand of the product due to its applications as both topical and injectable anesthetic. The drugs such as articaine and ropivacaine are estimated to register promising growth during the forecast period.
Injectable anesthetic segment is projected to dominate the market
On the basis of drug applications, the market is bifurcated into surface anaesthetic and injectable anaesthetic. The injectable anesthetic segment is projected to dominate the market owing to the wide use of the injectable in different surgical procedures. The injectable anesthetics is highly effective and has minimal side-effects. The surface anesthetic segment, however, is anticipated to grow at a fast pace in the coming time as there is increased research in the field and advancement in drug delivery system.
North America is anticipated to constitute a major market share
In terms of regions, the global local anesthesia drugs market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of the North America is anticipated to constitute a major market share owing to the high population of the region as well as great number of surgeries in the region. The US accounted for more than 25% of the total global surgeries completed in 2019. The high per capita income, an upsurge in the prevalence of chronic diseases, upgraded access to healthcare, and rising geriatric population are propelling the market in this region.
Europe, however, is one of the fastest growing regions and is expected to hold a key share of the market in the coming future as developments in surgical procedures, the growing volume of cosmetic and dental surgeries, and rising use of local anesthetics in post-operative pain treatment in the region. The other regions including Latin America and Asia Pacific are projected to exhibit lucrative growth rate during the forecast period due to the high population and inclining number of surgeries in these regions.
Segments
Segments Covered in the Report
The global local anesthesia drugs market has been segmented on the basis of
Products
- Umbilical Cord
- Bupivacaine
- Ropivacaine
- Lidocaine
- Chloroprocaine
- Prilocaine
- Benzocaine
- Others
Drug Applications
- Injectable Anaesthetic
- Surface Anaesthetic
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Astrazeneca PLC
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Hikma Pharmaceuticals PLC
- Baxter International Inc.
- Hospira, Inc.
- AbbVie Inc.
- Fresenius Se & Co. Kgaa.
Competitive Landscape
Key players competing in the global local anesthesia drugs market are Astrazeneca PLC; Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Hikma Pharmaceuticals PLC; Baxter International Inc.; Hospira, Inc.; AbbVie Inc.; and Fresenius Se & Co. Kgaa.
Request For Customization
Enquiry Before Buying
Speak With Analyst
